The Patent Finder

Bionor Pharma ASA

Also on record
Records under this name other than patents Bionor Pharma ASA holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Bionor Pharma ASA

PatentTitleStatus Expires Confidence
US 10,335,482Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,501,499Peptides derived from viral proteins for use as immunogens and dosage reactants
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,925,691Drill bit
Formerly held
Lapsed on the fee record
Ended Mar 27, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 27, 2026From the USPTO record
US 10,449,245Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent
Formerly held
Lapsed on the fee record
Ended Oct 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 22, 2023From the USPTO record
US 10,143,737Method for the vaccination against HIV
Formerly held
Lapsed on the fee record
Ended Dec 4, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 4, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited